Drug Pricing, Immunization and Magazine

UK enacts law to decentralise manufacture of personalised treatments

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? The legislation also supports the use of mobile manufacturing units, offering close-to-home treatment for patients too unwell to travel, or whose weakened immune systems mean hospital visits carry extra risk.

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Hospitals Packaging

Juvenescence enhances AI drug discovery with Ro5 acquisition

Pharmaceutical Technology

JUNE 6, 2025

This integration will reinforce Juvenescence’s pipeline in cardio-metabolism, cognition, immunity and cellular repair sectors. Can pharma tariffs “Make America Manufacture Again”? Incorporating Ro5’s AI platform into Juvenescence is expected to accelerate the development of AI-enabled treatments.

Communication

Communication Hospitals Drug Pricing Packaging

J&J seeks FDA approval for icotrokinra to treat psoriasis

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? PsO is an immune-mediated disease characterised by rapid skin cell proliferation leading to inflamed plaques that can cause discomfort or pain. Credit: design_cam/Shutterstock.com.

Immunization

Immunization Immunity Packaging Communication

Kling Bio and Sanofi link for antibodies and epitopes discovery

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? It employs a function-first screening workflow to reveal rare and effective immune targets, thereby fast-tracking the next-generation prophylactics and treatments development.

Vaccines

Vaccines Packaging Communication Immunization

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

Pharmaceutical Technology

JULY 1, 2025

The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. How will RFK Jr’s American dream for vaccines play out? Credit: HenadziPechan/Shutterstock.

Packaging

Packaging Communication Hospitals Drug Pricing

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? The technology stabilises viral proteins in their native shape, which may lead to more effective immune responses.

Health and Personal Care Stores

Health and Personal Care Stores Vaccines Packaging Communication

Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma

Pharmaceutical Technology

JULY 3, 2025

By GlobalData Learn more about Strategic Intelligence Boxed warnings are common for T-cell directing drugs, and Lynozyfic is no different. How will RFK Jr’s American dream for vaccines play out? It is unclear how Regeneron will challenge J&J and Pfizer in MM, who both reached the market first but have less convenient dosing options.

Packaging

Packaging Communication Hospitals Drug Pricing

AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline

Pharmaceutical Technology

JULY 1, 2025

A preliminary look at the data from Capstan has revealed strong B-cell depletion – the aim of the treatment is to achieve an ‘immune reset’ by repopulation of healthy B cells. How will RFK Jr’s American dream for vaccines play out? Investors shared positive sentiment in the acquisition, with shares in NYSE-listed AbbVie closing 1.7%

Insurance Coverage and Processing

Insurance Coverage and Processing Packaging Communication Hospitals

Chugai and Gero link on antibody drugs for age-related conditions

Pharmaceutical Technology

JULY 8, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Reports LOA and PTSR Model - Immune Globulin (Human) in Chronic Lymphocytic. Reports LOA and PTSR Model - Immune Globulin (Human) in Chronic Lymphocytic. How will RFK Jr’s American dream for vaccines play out?

Immunization

Immunization Immunity Packaging Hospitals

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. That is instead recommended by the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP).

Labelling

Labelling Vaccines Insurance Coverage and Processing Packaging

EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma

Pharmaceutical Technology

JULY 11, 2025

Its design minimises interaction with Fc-gamma (Fcγ) receptors on macrophages, enhancing the ability of the body’s immune cells to recognise and combat tumours. How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Hospitals Biosimilars Communication

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Pharmaceutical Technology

JULY 15, 2025

The share price in the company had climbed 3.6% LaNova’s drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality. How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Drug Development

Brii Biosciences and Joincare sign licence agreement for BRII-693

Pharmaceutical Technology

JULY 4, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. How will RFK Jr’s American dream for vaccines play out?

Hospitals

Hospitals Packaging Communication Immunization

LEO Pharma secures rights to Boehringer’s Spevigo for $105m

Pharmaceutical Technology

JULY 15, 2025

LEO’s new asset is a monoclonal antibody that blocks the activation of the interleukin-36 (IL-36) receptor – a key signalling pathway in the immune system implicated in the pathogenesis of several autoinflammatory diseases. How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Vaccines

RFK Jr axes vaccine advisory committee members

Pharmaceutical Technology

JUNE 10, 2025

The US department of Health and Human Services (HHS) has culled the 17 Biden-appointed members on the Advisory Committee for Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC) in a move observers warn is liable to further fuel the spread of vaccine-preventable illnesses. lev radin via Shutterstock.

Vaccines

Vaccines Insurance Coverage and Processing Drug Pricing Immunization

Leading medical groups sue RFK Jr and HHS over ‘hostile’ vaccine policies

Pharmaceutical Technology

JULY 8, 2025

The medical groups also pointed to sweeping changes made on the CDC’s Advisory Committee for Immunization Practices (ACIP), the committee responsible for reviewing vaccine data and issuing official government recommendations on immunisations. How will RFK Jr’s American dream for vaccines play out?

Vaccines

Vaccines Packaging Communication Hospitals

Amid sector disruption, biotech must focus on 'fundamentals'

pharmaphorum

JUNE 18, 2025

EYs latest Biotech Beyond Borders report acknowledges the seismic changes in the US in the last few months, including cuts to NIH funding , staff reductions at the FDA which could affect its ability to review and approve new products, the threat of tariffs on medicines, and new drug pricing proposals such as Trumps most favoured nation policy.

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Immunization

Pharmacist Digest

UK enacts law to decentralise manufacture of personalised treatments

Juvenescence enhances AI drug discovery with Ro5 acquisition

Trending Sources

J&J seeks FDA approval for icotrokinra to treat psoriasis

Kling Bio and Sanofi link for antibodies and epitopes discovery

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront

Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma

AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline

Chugai and Gero link on antibody drugs for age-related conditions

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Brii Biosciences and Joincare sign licence agreement for BRII-693

LEO Pharma secures rights to Boehringer’s Spevigo for $105m

RFK Jr axes vaccine advisory committee members

Leading medical groups sue RFK Jr and HHS over ‘hostile’ vaccine policies

Amid sector disruption, biotech must focus on 'fundamentals'

Stay Connected